{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T16:01:34Z","timestamp":1792512094521,"version":"4.5.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2022A1515110989"],"award-info":[{"award-number":["2022A1515110989"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2023\\u202FM740834"],"award-info":[{"award-number":["2023\\u202FM740834"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002402","name":"Sun Yat-sen University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002402","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82202273"],"award-info":[{"award-number":["82202273"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["51933011"],"award-info":[{"award-number":["51933011"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82172043"],"award-info":[{"award-number":["82172043"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People&apos;s Republic of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.jconrel.2024.10.069","type":"journal-article","created":{"date-parts":[[2024,11,6]],"date-time":"2024-11-06T04:41:10Z","timestamp":1730868070000},"page":"913-929","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["Anti-CTLA-4 antibody self-presented dendritic cell nanovesicles boost the immunotherapy of hepatocellular carcinoma after microwave ablation"],"prefix":"10.1016","volume":"376","author":[{"given":"Tan","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liteng","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gengjia","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wensou","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingyue","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xintao","family":"Shuai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kangshun","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2024.10.069_bb0005","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/s41575-022-00704-9","article-title":"Evolving therapeutic landscape of advanced hepatocellular carcinoma","volume":"20","author":"Yang","year":"2023","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jconrel.2024.10.069_bb0010","first-page":"1097","article-title":"Molecular and immune landscape of hepatocellular carcinoma to guide therapeutic decision making","volume":"10","author":"Dhanasekaran","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.jconrel.2024.10.069_bb0015","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1007\/s00262-020-02734-1","article-title":"Microwave ablation enhances tumor-specific immune response in patients with hepatocellular carcinoma","volume":"70","author":"Leuchte","year":"2021","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.jconrel.2024.10.069_bb0020","article-title":"Intratumoral lactate depletion based on injectable nanoparticles\u2212 hydrogel composite system synergizes with immunotherapy against Postablative hepatocellular carcinoma recurrence","volume":"13","author":"Chen","year":"2023","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.jconrel.2024.10.069_bb0025","doi-asserted-by":"crossref","first-page":"104","DOI":"10.3390\/cancers13010104","article-title":"Histological correlation for radiofrequency and microwave ablation in the local control of hepatocellular carcinoma (HCC) before liver transplantation: a comprehensive review","volume":"13","author":"Habibollahi","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.jconrel.2024.10.069_bb0030","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12123796","article-title":"Microwave ablation versus radiofrequency ablation for treatment of hepatocellular carcinoma: a meta-analysis of randomized controlled trials","volume":"12","author":"Facciorusso","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.jconrel.2024.10.069_bb0035","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1148\/radiol.15141864","article-title":"Evaluation of the effect of cumulative operator experience on hepatocellular carcinoma recurrence after primary treatment with radiofrequency ablation","volume":"276","author":"Lee","year":"2015","journal-title":"Radiology"},{"key":"10.1016\/j.jconrel.2024.10.069_bb0040","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.ejso.2021.08.035","article-title":"Therapeutic efficacy of microwave coagulation versus liver resection for hepatocellular carcinoma within the Milan criteria: a propensity score matching analysis","volume":"48","author":"Feng","year":"2022","journal-title":"Eur. J. Surg. Oncol."},{"key":"10.1016\/j.jconrel.2024.10.069_bb0045","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.3390\/cancers13061295","article-title":"Comparing the safety and efficacy of microwave ablation using THERMOSPHERETM technology versus radiofrequency ablation for hepatocellular carcinoma: a propensity score-matched analysis","volume":"13","author":"Kuroda","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.jconrel.2024.10.069_bb0050","article-title":"Targeting PI3K\u03b3\/AKT pathway remodels LC3-associated phagocytosis induced immunosuppression after radiofrequency ablation","volume":"9","author":"Liu","year":"2022","journal-title":"Adv. Sci."},{"key":"10.1016\/j.jconrel.2024.10.069_bb0055","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1002\/hep.32585","article-title":"Kuang eliminating METTL1-mediated accumulation of PMN-MDSCs prevents hepatocellular carcinoma recurrence after radiofrequency ablation","volume":"77","author":"Zeng","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.jconrel.2024.10.069_bb0060","doi-asserted-by":"crossref","first-page":"855","DOI":"10.3390\/cancers16050855","article-title":"Thermal ablation combined with immune checkpoint blockers: a 10-year monocentric experience","volume":"16","author":"Bonnet","year":"2024","journal-title":"Cancers"},{"key":"10.1016\/j.jconrel.2024.10.069_bb0065","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.jtho.2018.03.008","article-title":"Clinical features and management of acquired resistance to PD-1 axis inhibitors in 26 patients with advanced non\u2013small cell lung cancer","volume":"13","author":"Gettinger","year":"2018","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.jconrel.2024.10.069_bb0070","doi-asserted-by":"crossref","first-page":"2842","DOI":"10.21037\/tlcr-20-1075","article-title":"Thermal ablation in non-small cell lung cancer: a review of treatment modalities and the evidence for combination with immune checkpoint inhibitors","volume":"10","author":"Rangamuwa","year":"2021","journal-title":"Transl. Lung Cancer R."},{"key":"10.1016\/j.jconrel.2024.10.069_bb0075","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1093\/annonc\/mdx286","article-title":"Tumour-and class-specific patterns of immune-related adverse events of immune checkpoint inhibitors: a systematic review","volume":"28","author":"Khoja","year":"2017","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.jconrel.2024.10.069_bb0080","doi-asserted-by":"crossref","first-page":"3520","DOI":"10.1158\/1078-0432.CCR-10-3126","article-title":"PROVENGE (Sipuleucel-T) in prostate cancer: the first FDA-approved therapeutic cancer vaccine","volume":"17","author":"Cheever","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2024.10.069_bb0085","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/s41568-021-00346-0","article-title":"Therapeutic cancer vaccines","volume":"21","author":"Saxena","year":"2021","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jconrel.2024.10.069_bb0090","first-page":"911","article-title":"Cancer vaccines: the next immunotherapy frontier","volume":"3","author":"Lin","year":"2022","journal-title":"Nat. Can."},{"key":"10.1016\/j.jconrel.2024.10.069_bb0095","doi-asserted-by":"crossref","first-page":"8047","DOI":"10.1038\/s41467-023-43914-8","article-title":"Metabolic tagging of extracellular vesicles and development of enhanced extracellular vesicle based cancer vaccines","volume":"14","author":"Bhatta","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2024.10.069_bb0100","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.ade0625","article-title":"Engineering an active immunotherapy for personalized cancer treatment and prevention of recurrence","volume":"9","author":"Wu","year":"2023","journal-title":"Sci. Adv."},{"key":"10.1016\/j.jconrel.2024.10.069_bb0105","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/s41565-022-01098-0","article-title":"A nanovaccine for antigen self-presentation and immunosuppression reversal as a personalized cancer immunotherapy strategy","volume":"17","author":"Liu","year":"2022","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.jconrel.2024.10.069_bb0110","doi-asserted-by":"crossref","first-page":"9543","DOI":"10.1128\/MCB.25.21.9543-9553.2005","article-title":"CTLA-4 and PD-1 receptors inhibit T-cell activation by distinct mechanisms","volume":"25","author":"Parry","year":"2005","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.jconrel.2024.10.069_bb0115","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1172\/JCI81137","article-title":"Dendritic cell\u2013derived exosomes for cancer therapy","volume":"126","author":"Pitt","year":"2016","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jconrel.2024.10.069_bb0120","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.7150\/jca.57334","article-title":"A snapshot of the PD-1\/PD-L1 pathway","volume":"12","author":"Ghosh","year":"2021","journal-title":"J. Cancer"},{"key":"10.1016\/j.jconrel.2024.10.069_bb0125","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1038\/s41565-023-01378-3","article-title":"Non-invasive activation of intratumoural gene editing for improved adoptive T-cell therapy in solid tumours","volume":"18","author":"Chen","year":"2023","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.jconrel.2024.10.069_bb0130","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2023.2175506","article-title":"Tumor-infiltrating lymphocytes for melanoma immunotherapy","volume":"12","author":"Kepp","year":"2023","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.jconrel.2024.10.069_bb0135","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1038\/s41563-020-0680-1","article-title":"Metabolic labeling and targeted modulation of dendritic cells","volume":"19","author":"Wang","year":"2020","journal-title":"Nat. Mater."},{"key":"10.1016\/j.jconrel.2024.10.069_bb0140","article-title":"Click-chemistry-mediated cell membrane glycopolymer engineering to potentiate dendritic cell vaccines","volume":"136","author":"Yang","year":"2024","journal-title":"Angew. Chem."},{"key":"10.1016\/j.jconrel.2024.10.069_bb0145","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/s41551-021-00820-y","article-title":"Efficient recovery of potent tumour-infiltrating lymphocytes through quantitative immunomagnetic cell sorting","volume":"6","author":"Wang","year":"2022","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.jconrel.2024.10.069_bb0150","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/s41571-023-00848-w","article-title":"Tumour-infiltrating lymphocyte therapy for patients with advanced-stage melanoma","volume":"21","author":"Klobuch","year":"2024","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.jconrel.2024.10.069_bb0155","doi-asserted-by":"crossref","first-page":"5049","DOI":"10.1038\/s41467-023-40886-7","article-title":"Metabolic glycan labeling immobilizes dendritic cell membrane and enhances antitumor efficacy of dendritic cell vaccine","volume":"14","author":"Han","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2024.10.069_bb0160","doi-asserted-by":"crossref","first-page":"6953","DOI":"10.1038\/s41467-023-42725-1","article-title":"An in situ dual-anchoring strategy for enhanced immobilization of PD-L1 to treat autoimmune diseases","volume":"14","author":"Wang","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2024.10.069_bb0165","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1007\/s12094-023-03126-4","article-title":"Targeting CXCL9\/10\/11\u2013CXCR3 axis: an important component of tumor-promoting and antitumor immunity","volume":"25","author":"Pan","year":"2023","journal-title":"Clin. Transl. Oncol."},{"key":"10.1016\/j.jconrel.2024.10.069_bb0170","doi-asserted-by":"crossref","first-page":"7458","DOI":"10.1038\/ncomms8458","article-title":"Non-redundant requirement for CXCR3 signalling during tumoricidal T-cell trafficking across tumour vascular checkpoints","volume":"6","author":"Mikucki","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2024.10.069_bb0175","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.ccell.2017.04.003","article-title":"Tumor-residing Batf3 dendritic cells are required for effector T cell trafficking and adoptive T cell therapy","volume":"31","author":"Spranger","year":"2017","journal-title":"Cancer Cell"}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365924007429?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365924007429?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:45:03Z","timestamp":1777509903000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365924007429"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":35,"alternative-id":["S0168365924007429"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2024.10.069","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-CTLA-4 antibody self-presented dendritic cell nanovesicles boost the immunotherapy of hepatocellular carcinoma after microwave ablation","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2024.10.069","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}